Press Release: R&DABS : Research & Diagnostic Antibodies Announces the Launch of the PliNOSa Assay Kit, a First-In-Class CE Marked IVD Test for the Onset of Sepsis
LAS VEGAS--(BUSINESS WIRE)--R&D Abs' PliNOSa Assay kit is now CE marked and cleared for marketing in the EU as an IVD medical device.
Read full article »
CEO
R&DABS is a Private company. R&DABS generates $112.2K in revenue per employee R&DABS has 1 followers on Owler.